Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Oncology"

1222 News Found

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
Hospitals | June 23, 2026

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,


KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
News | June 18, 2026

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

CEO Stéphane Bancel framed the changes as essential to scaling the business


Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
News | June 15, 2026

Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push

Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies
News | June 05, 2026

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments


Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026
R&D | May 25, 2026

Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026

The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


AbbVie signals major oncology momentum at ASCO
R&D | May 25, 2026

AbbVie signals major oncology momentum at ASCO

With standout ADC and t-cell engager response data across hard-to-treat cancers